FDA Inspection 1007059 — Boiron Inc.
The FDA completed an inspection of Boiron Inc. on February 14, 2017 in Newtown Square, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 14, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Newtown Square, PA (United States)